Recombinant Belatacept Biosimilar 抗体
Our Local Distributor
北京 101111
Quick Overview for Recombinant Belatacept Biosimilar 抗体 (ABIN7795081)
抗原
抗体类型
适用
宿主
克隆类型
应用范围
质量等级
-
-
Expression System
- Mammalian cells
-
原理
- Belatacept Biosimilar
-
产品特性
- Belatacept (trade name Nulojix, Bristol-Myers-Squibb), a fusion protein of a Fc fragment (human IgG1 isotype) and the extracellular domain of CTLA-4, can be used to extend graft survival while limiting the toxicity generated by standard immune suppressing regimens, such as calcineurin inhibitors. Belatacept differs from abatacept (trade name Orencia) by only 2 amino acids. The CTLA-4 protein is important for T-cell costimulation and selectively blocks the process of T-cell activation.
-
纯化方法
- Protein A or G affinity column
-
纯度
- >95 % by reducing SDS-PAGE
-
内毒素水平
- < 1 EU per 1 mg of the protein by the LAL method
-
-
-
应用备注
- Optimal working dilution should be determined by the investigator.
-
限制
- 仅限研究用
-
-
-
状态
- Liquid
-
浓度
- > 3 mg/mL
-
储存条件
- 4 °C,-20 °C
-
储存方法
- Short time 2 to 8°C as supplied. Long time -20°C to -70°C as supplied.
-
-
- Belatacept Biosimilar
-
物质类
- Biosimilar
抗原
-